Clinical Trial Biomarker Monitoring
Oncology, Autoimmune, Metabolic, Neurodegenerative diseases
Pre-clinicalActive
Key Facts
Indication
Oncology, Autoimmune, Metabolic, Neurodegenerative diseases
Phase
Pre-clinical
Status
Active
Company
About Kiffik Biomedical
Kiffik Biomedical is an early-stage diagnostics company pioneering a novel platform for continuous, non-invasive biomarker monitoring from interstitial fluid (ISF). Its core technology, KIFFIK EXP, is a wearable device that captures molecular data not readily available in blood, targeting applications in clinical trial optimization, companion diagnostics, and remote patient monitoring. The company is currently in the investigational stage, partnering with pharmaceutical and diagnostic leaders to validate its platform across multiple therapeutic areas, including oncology, women's health, and military medicine.
View full company profile